Codivir suppresses SARS-Cov-2 viral replication and stabilizes clinical outcome: In vitro and Phase I clinical trial results

BACKGROUND: Treatment of severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2) remains a significant challenge in the face of increased worldwide morbidity and mortality. The acute illness caused by SARS-CoV-2 is initiated by a viral phase, followed by an inflammatory phase. Numerous...

Descripción completa

Detalles Bibliográficos
Autores principales: Kolben, Yotam, Finkelshtein, Eynat, Naftali, Esmira, Kenig, Ariel, Kessler, Asa, Cardoso, Florentino, Lisovoder, Nadya, Schwartz, Asaf, Elbirt, Daniel, Maayan, Shlomo, Ilan, Yaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Applied Systems srl 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348448/
https://www.ncbi.nlm.nih.gov/pubmed/37457644
http://dx.doi.org/10.15190/d.2022.17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348448/
https://www.ncbi.nlm.nih.gov/pubmed/37457644
http://dx.doi.org/10.15190/d.2022.17

Ejemplares similares